ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

TSTL Tristel Plc

445.00
0.00 (0.00%)
Last Updated: 08:00:12
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tristel Plc LSE:TSTL London Ordinary Share GB00B07RVT99 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 445.00 440.00 450.00 445.00 445.00 445.00 2,715 08:00:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 36.01M 4.46M 0.0941 47.29 210.93M
Tristel Plc is listed in the Med, Dental, Hosp Eq-whsl sector of the London Stock Exchange with ticker TSTL. The last closing price for Tristel was 445p. Over the last year, Tristel shares have traded in a share price range of 327.50p to 499.00p.

Tristel currently has 47,400,993 shares in issue. The market capitalisation of Tristel is £210.93 million. Tristel has a price to earnings ratio (PE ratio) of 47.29.

Tristel Share Discussion Threads

Showing 3976 to 4000 of 4000 messages
Chat Pages: 160  159  158  157  156  155  154  153  152  151  150  149  Older
DateSubjectAuthorDiscuss
22/4/2024
16:35
Cheers Piedro, that was before my time. 2016 when I first bought. I agree with your view.
melton john
22/4/2024
15:32
Here is the RNS ...

RNS Number : 2836Z
18 September 2009
Licensing agreement for the Americas ...
Licensing agreement with The Clorox Company of the United States
Tristel plc ('Tristel'), the specialist infection and contamination control company, announces that it has licensed its proprietary chlorine dioxide chemistry to The Clorox Company ('Clorox'), a leading manufacturer and marketer of consumer products, including its namesake bleach. ... ...

I always have considered it as a maneouvre by Clorox to block Tristel from the US

piedro
22/4/2024
08:14
A while since I owned TSTL Piedro but still on mmy watch list. I must have missed the Clorox deal you refer to. Do you have a link please.
melton john
22/4/2024
07:30
FYI ...

22 April 2024
HeiQ Synbio Secures Ecolab Contract Win
HeiQ Plc (LSE: HEIQ), a leading company in materials innovation and hygiene technologies, is pleased to announce that its Life Sciences Business Unit has signed a significant distributor agreement with Ecolab Inc. (NYSE: ECL) to supply HeiQ Synbio Cleaners, a product from the Company's industrial biotechnology platform that uses natural synbiotic ingredients to achieve high efficacy cleaning. ...



- sort of reminds me of the Tristel/Clorox deal

piedro
10/4/2024
20:56
Do I see an imminent 2 yr high?
wad collector
09/4/2024
22:02
LOL

To much of a liability with BYOT and
they also have the MadiChem boys on board.

Much better to wait for them to go bankrupt
and pick up and choose the pieces.

AIMHO, BWDIK.

piedro
09/4/2024
20:18
I'm suggesting Tristel buys Byotrol.
loafofbread
09/4/2024
19:58
He is encouraging Tristel holders to buy Byotrol. If you read his first posting. So read before you get rude.
wad collector
09/4/2024
17:34
Hey knucklehead have you got the right stock
petewy
09/4/2024
16:43
Err, why would anyone want to buy into such a failing company? I note your postings for months as the price fell to practically nothing ; you must have lost a lot.
wad collector
07/4/2024
20:33
If he was happy to splash out up to £2M on this deal, I would think £4M for the lot would be an absolute steal!

23 March 2020
TRISTEL plc
("Tristel" or the "Company")

Know-How License and Product Supply Agreement with Byotrol plc ("Byotrol")

Tristel plc (AIM: TSTL), the manufacturer of infection prevention and contamination control products announces that it has entered into a know-how licence and commercial collaboration with Byotrol ("Agreement"). The Agreement relates to the joint development of a biocidal formulation and Byotrol's development of two additional biocidal products and formulations that will be supplied and licensed to Tristel.
Jointly developed formulation
This formulation will create a unique surface disinfectant product for hospitals by combining the two companies' core technologies.
The formulation combines Tristel's chlorine dioxide chemistry, which is sporicidal meaning that it has the highest level of disinfection efficacy, with ACTIZONE, a Solvay S.A. technology developed in collaboration with Byotrol and which enables a disinfectant to have long-lasting efficacy on a surface for an 8-hour period after first application. Tristel will incorporate the jointly developed formulation in several packaging formats under the family name "Tristel8". These products will be unique worldwide in combining sporicidal efficacy with residual disinfection efficacy.
Additional biocidal products
In addition, Byotrol will licence two biocidal formulations to Tristel for incorporation in its surface disinfectants range which is branded Cache. Cache represents a novel approach to today's very relevant issues of hospital hygiene and environmental concern.
The Byotrol products and formulations give Tristel access to intermediate level disinfectants that are effective against bacteria, viruses and yeasts in accordance with the requirements of European Test Norms. The disinfectants will be for use in hospitals and will conform with the requirements of the European Biocidal Products Registration (BPR), and the United Kingdom equivalent that will come into force post Brexit. As this legislation is implemented throughout the United Kingdom and Europe during the coming years various active ingredients that are commonly incorporated in hospital grade disinfectants will be withdrawn from use. Tristel has previously incorporated some of these active ingredients in the intermediate level disinfectants that it presents to hospitals alongside its high-performance chlorine dioxide disinfectants. The Agreement will ensure that Tristel will continue to comply fully with the future regulatory environment that will govern the manufacture and sale of disinfectants for surface disinfection.
Commercial arrangements
Tristel will manufacture all the products deriving from the formulations, whilst Byotrol will supply the ACTIZONE material. Byotrol will receive payments from Tristel based upon volumes manufactured and product sales. Tristel will be responsible for branding and global sales and marketing through its thirteen subsidiaries and 35 international distributors. We expect sales of these new products to commence in the next financial year.
Commenting on the collaboration and current trading conditions, Paul Swinney, Chief Executive of Tristel, said: "Tristel and Byotrol are both specialist infection prevention companies, and in recent years we have forged a close working relationship. This collaboration holds great promise for both businesses. For Tristel it provides us a future-proofed intermediate grade disinfectant that we will incorporate into our hospital surface disinfectants product portfolio.
"The second key element of the arrangement is that we will combine a sporicidal high-performance disinfectant, which has an unrivalled kill time, with long-lasting disinfection activity that is proven to last for eight hours in accordance with PAS2424, a test developed with BSI and currently under detailed review by the EU for EN status. This combination of technologies creates a ground-breaking proposition. It is akin to clearing a crowd out of a stadium in 30 seconds and then keeping the doors closed to stop anyone re-entering. We must caution, however, that adoption of new infection prevention technology is often slow in healthcare, as both our companies know from first-hand experience.

loafofbread
07/4/2024
17:04
I struggle to think of a worse move for TSTL to make than to acquire Byotrol. It has all the rights that it needs and has much more important things to concentrate on.
james188
07/4/2024
16:53
Assume you guys know you could pick up Byotrol before it goes private for 1X sales.

Buying it for 1p a share £4.3M would boost your share price much more than the cash/share outlay if you apply your current 5 X revenue rating going forward.

You have just paid them over £300k to buy back a tiny bit of their IP which shows the value in Byotrol.

It would be a shame if your CEO personal friendship with DT got in the way of a great result for Tristel share holders.

loafofbread
06/4/2024
20:35
Certainly is. 😊
apad

apad
06/4/2024
20:27
Keep up the good work on the website Piedro ; it is appreciated.
wad collector
25/3/2024
12:43
Buying a few sub £4.00 would be even better before the shares rerates to £5 - £6 plus.
z1co
22/3/2024
14:32
Sliding daily... Excellent. Hopefully I can buy back the shares I sold at 477! Am thinking 420-430 would tempt me back.
zimbtrader
11/3/2024
17:50
Another couple of delayed trades ( BUY'S ) of 200,000 @ £4.66 and 72,409 @ £4.675 from last Friday reported after the close today.

It's no surprise at all to these cheap shares being snapped up by buyer/s.

Will go ex. dividend in 10 days time for a very decent 5.24p

z1co
11/3/2024
15:47
The share price rise today is saying a lot of the stock sold after the results has already been bought by buyers.
z1co
08/3/2024
18:51
There were a total of 7 BUY trades of 50,000 and also another BUY of 218,160.As fast as someone is selling there's definitely a buyer/s picking up these cheap shares.
z1co
08/3/2024
16:24
Quite a few very large buy trades gone through this pm , buyer/s taking advantage.
z1co
08/3/2024
15:38
Yes the seller appeared on the 26/02/2024 hence no further rise in the share price.The seller will eventually finish , they always do and the shares will start climbing upwards again.

I'm tempted to buy more but i'm also waiting and watching and will hopefully pounce at the right time.

z1co
08/3/2024
13:11
Z1co, you won't often get a quote to buy 10k shares here because the EMS is 1500, although you can right now because there is clearly a seller around.
74tom
08/3/2024
07:45
Promoting in India
piedro
07/3/2024
11:18
A few large buys reported yesterday after the close 20,363 @ £4.75 being one of them.

No quote being given to buy 10,000 shares at the moment.

z1co
Chat Pages: 160  159  158  157  156  155  154  153  152  151  150  149  Older

Your Recent History

Delayed Upgrade Clock